Ingmar Gorman

Dr. Ingmar Gorman is a psychologist who specializes in assisting populations who have had experiences with psychedelics. He is the co-founder of Fluence, which trains mental health providers in psychedelic integration and therapy.


He is the site co-principal investigator and therapist on a MAPS Phase 3 clinical trial studying MDMA-assisted psychotherapy for post-traumatic stress disorder. He also co-founded the Psychedelic Education and Continuing Care Program in 2015 and directed the program until 2019. Dr. Gorman is a board member of Horizons Media, Inc., a not-for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics. He completed his NIH funded postdoctoral fellowship at New York University in 2019.

Notable Research Papers

Find more on Google Scholar or PubMed

In our database you will also find him as an author on many more papers.


He has given public talks:

More media:

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account